NCT06562777View on ClinicalTrials.gov

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Non-Interventional Study

Non-Interventional Study

Trial Locations (1)

97239

RECRUITING

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER